Quantitative chemical proteomics enabled affinity-isolation and enrichment of the tyrosine receptor kinase TrkA and protein isolation was competed by the inhibitors purvalanol B and staurosporine in a dose-related manner. These methods will advance occupancy biomarker development and our understanding of TrkA biochemistry in disease.